High-throughput screening (HTS) remains the key approach for finding hits and leads in the field of drug discovery. As the number of compounds available for screening has increased dramatically, industrialization and automation of the process have improved the ability to deal with larger numbers of compounds. Creative Biostructure provides high-quality custom MagHelix™ HTS assay development services for the pharmaceutical and biotechnological industries. We can start from a specific target/cell line or assist an ongoing lead discovery programs based on the requirements of our customers.